What Is the Difference between Hydrocodone and Codeine?

Hydrocodone, also known as dihydrocodeinone, is a chemical with white to pale yellow crystals. The molecular formula is C18H21NO3, the molecular weight is 299.36400, and the melting point is 198 ° C. Hydrocodone is an antipyretic and analgesic. It is mainly used clinically for cough and relieves moderate to severe pain caused by various reasons. Currently available varieties: paracetamol hydrocodone, 5mg hydrocodone bitartrate and 500mg paracetamol.

Hydrocodone, also known as dihydrocodeinone, is a chemical with white to pale yellow crystals. The molecular formula is C18H21NO3, the molecular weight is 299.36400, and the melting point is 198 ° C. Hydrocodone is an antipyretic and analgesic. It is mainly used clinically for cough and relieves moderate to severe pain caused by various reasons. Currently available varieties: paracetamol hydrocodone, 5mg hydrocodone bitartrate and 500mg paracetamol.
Chinese name
Hydrocodone
Foreign name
Hydrocodone
CAS number
125-29-1
Molecular formula
C18H21NO3

Hydrocodone compounds

Hydrocodone Basic Information

Chinese name: dihydrocodeinone
English name: hydrocodone
English alias: Bekadid; (4R, 4aR, 7aR, 12bS) -9-methoxy-3-methyl-1,2,4,4a, 5,6,7a, 13-octahydro-4,12-methanobenzofuro [3,2 -e] isoquinoline-7-one; hidrocodona; 7,8-dihydrocodeinone; Dicodid;
CAS number: 125-29-1
Molecular formula: C 18 H 21 NO 3
Chemical structure:
Molecular weight: 299.36400
Exact mass: 299.15200
PSA: 38.77000
LogP: 1.87120 [1]

Hydrocodone physicochemical properties

Appearance and properties: white to light yellow crystal
Density: 1.31 g / cm3
Melting point: 198ºC
Boiling point: 461.4ºC at 760 mmHg
Flash point: 232.9ºC
Refractive index: 1.633
Vapor pressure: 1.07E-08mmHg at 25 ° C [1]

Hydrocodone Basic Information

[ Common name ] Hydrocodone
[ English name ] hydrocodone
[ Introduction ] Hydrocodone is a semi-synthetic anesthetic, analgesic and antitussive drug. It has a variety of activities similar to the codeine properties. Most of these effects are related to the central nervous system and smooth muscle. In other words, it is an anesthetic that can be used to relieve pain.
Available varieties: Paracetamol hydrocodone tablets, 5mg hydrocodone bitartrate and 500mg paracetamol. [2]

Hydrocodone usage and dosage

Oral administration
Antitussive, moderate to severe pain
Adult: Hydrocodone tartrate: 5-10 mg every 4-6 hours. [2]

Hydrocodone pharmacological action

Hydrocodone is a phenanthrene derivative and is an opioid analgesic. A commonly used formulation is hydrocodone tartrate, which is mainly used to relieve irritating cough. The drug is often used in combination with acetaminophen to relieve moderate to severe pain.
Metabolism: May be metabolized in the liver.
Excretion: Most are excreted through urine. Healthy adult half-life: 3.8 hours. [2]

Hydrocodone pharmacokinetics

Five adult men took 10 mg of hydrocodone orally. The average peak plasma concentration was 23.6 ± 5.2 ng / ml, the peak time was 1.3 ± 0.3 h, and the plasma t 1/2 was 3.8 ± 0.3 h. Hydrocodone exhibits complex metabolic patterns including O-demethyl, N-demethyl and 6-ketone reduction to 6- and 6- hydroxyl metabolites [2] .

Hydrocodone precautions

Head trauma, acute alcoholism, convulsive disease, elevated intracranial pressure, elderly, weak, hypothyroidism, adrenal insufficiency, asthma, kidney or liver damage, enlarged prostate, hypotension, shock, inflammation or obstruction Intestinal disease, myasthenia gravis, drug dependent patients, children <1 year old, pregnant women who are breastfeeding should use with caution. Affects the ability to drive and operate machinery [2] .

Hydrocodone adverse reactions

Nausea, vomiting, constipation, drowsiness, confusion, central nervous system abnormalities, cardiovascular disease, dry mouth, sweating, flushing, decreased libido, narrowed pupils, convulsions.
Serious adverse reactions: respiratory depression [2] .

FDA Hydrocodone FDA pregnancy classification

Animal studies have proven that the drug is harmful to the fetus (teratogenic or embryonic death, etc.), or there have not been controlled pregnant women, or pregnant women and animals. This class of drugs should only be used after weighing the benefits to the pregnant woman over the harm to the fetus.

Hydrocodone drug interactions

1. Drinking alcohol while taking hydrocodone tartrate tablets can enhance central inhibition.
2. The use of hydrocodone tartrate tablets in patients receiving monoamine oxidase inhibitor therapy can enhance central inhibition.
3. Combined with sedative hypnotics and tricyclic antidepressants can enhance its sedative, analgesic and respiratory depression effects.
4. Combined with its anesthetic, it can aggravate central inhibitory effect.
5. Enhanced effects when combined with other central nervous system inhibitors [2] .

IN OTHER LANGUAGES

Was this article helpful? Thanks for the feedback Thanks for the feedback

How can we help? How can we help?